GenJet? In Vitro DNA Tranfection Reagent for 3LL Cells¥ 1,560.00 購買(mǎi)數量:
請選擇:Description GenJet? DNA In Vitro Tranfection Reagent for 3LL cell is pre-optimized for transfecting 3LL cells. 3LL also called Lewis lung carcinoma was discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. Refer to the following optimal transfection conditions for maximal transfection efficiency on 3LL cells. GenJet? reagent, 1.0 ml, is sufficient for 300 to 600 transfections in 24 well plates or 150 to 300 transfections in 6 well plates. Summary of Optimal Transfection Conditions:
Transfection Results:
Storage Condition |